TJP1 and glioblastoma: The Cx43 mimetic peptide of the ZO-1 binding domain aCT1 that selectively inhibits Cx43 hemichannel activity and increases Cx43 dependent gap junction formation [60, 61], restores TMZ sensitivity to TMZ-resistant GBM cells [27].